Cited by 202Advanced Glycation End Products researchProtein Kinase Regulation and GTPase SignalingMelanoma and MAPK Pathways

The receptor for advanced glycation end‐products (RAGE) directly binds to ERK by a D‐domain‐like docking site

Ishihara, Katsuya, Tsutsumi, Kae, Kawane, Shiho, Nakajima, Motowo, Kasaoka, Tatsuhiko·2003·FEBS Letters

Abstract

The receptor for advanced glycation end‐products (RAGE)‐mediated cellular activation through the mitogen‐activated protein kinase (MAPK) cascade, activation of NF‐κB and Rho family small G‐proteins, cdc42/Rac, is implicated in the pathogenesis of inflammatory disorders and tumor growth/metastasis. However, the precise molecular mechanisms for the initiation of cell signaling by RAGE remain to be elucidated. In this study, proteins which directly bind to the cytoplasmic C‐terminus of RAGE were purified from rat lung extracts using an affinity chromatography technique and identified to be extracellular signal‐regulated protein kinase‐1 and ‐2 (ERK‐1/2). Their interactions were confirmed by immunoprecipitation of ERK‐1/2 from RAGE‐expressing HT1080 cell extracts with anti‐RAGE antibody. Furthermore, the augmentation of kinase activity of RAGE‐bound ERK upon the stimulation of cells with amphoterin was demonstrated by determining the phosphorylation level of myelin basic protein, an ERK substrate. In vitro binding studies using a series of C‐terminal deletion mutants of human RAGE revealed the importance of the membrane‐proximal cytoplasmic region of RAGE for the direct ERK–RAGE interaction. This region contained a sequence similar to the D‐domain, a ERK docking site which is conserved in some ERK substrates including MAPK‐interacting kinase‐1/2, mitogen‐ and stress‐activated protein kinase‐1, and ribosomal S6 kinase. These data suggest that ERK may play a role in RAGE signaling through direct interaction with RAGE.

Integrity signals

Registry

Crossref · 10.1016/s0014-5793(03)00846-9

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ERK directly interacts with the cytoplasmic tail of RAGE.

    “The protein contains no obvious signalling domains90, although extracellular signal-regulated kinase (eRK) was shown to directly interact with the cytoplasmic tail of RAGe97.”

    From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [97]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ishihara, K., Tsutsumi, K., Kawane, S., Nakajima, M., & Kasaoka, T.
Affiliations
Novartis (Japan) (JP)
Venue
FEBS Letters
Publisher
Wiley
Published
2003-08-06
Volume
550
Issue
1-3
Pages
107-113
ISSN
  • 0014-5793 (ISSN-L)
  • 1873-3468
OpenAlex
W1965497701
Cited by
201
References
47
Citations by year
2026: 3 · 2025: 4 · 2024: 2 · 2023: 5 · 2022: 10 · 2021: 8 · 2020: 7 · 2019: 6 · 2018: 6 · 2017: 9 · 2016: 9 · 2015: 6 · 2014: 12 · 2013: 10 · 2012: 9
FWCI
4.96
Type
journal article
Language
en
Open access
closed
Locations
  • FEBS Letters (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
Keywords
receptor for advanced glycation end products, RAGE, ERK1/2, D domain, MAPK signaling, protein-protein interaction, myelin basic protein phosphorylation, amphoterin, RAGE signaling
MeSH terms
Receptor for Advanced Glycation End Products, Amino Acid Sequence, Animals, Binding Sites, Cell Extracts, Cells, Cultured, Cytoplasm, Myelin Basic Protein, Humans, Lung, Male, Phosphorylation, Receptors, Immunologic, Conserved Sequence, Rats, Wistar, Sequence Deletion, Protein Structure, Tertiary, Mitogen-Activated Protein Kinase 1, Mitogen-Activated Protein Kinases, HMGB1 Protein, Mitogen-Activated Protein Kinase 3, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review